StockNews.AI
VTAK
StockNews.AI
216 days

Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC

1. VTAK is acquiring PeriKard, enhancing its product portfolio. 2. The acquisition involves issuing restricted VTAK stock for 100% interest.

2m saved
Insight
Article

FAQ

Why Bullish?

The acquisition could create value through expanded offerings, similar to past sector consolidations.

How important is it?

The acquisition is likely to significantly impact VTAK's future growth prospects.

Why Long Term?

Long-term growth expected from the addition of PeriKard's assets, similar to prior acquisitions boosting revenue.

Related Companies

FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to acquire PeriKard, LLC., in a transaction involving the issuance of restricted VTAK common stock for 100% of the LLC interests in PeriKard.

Related News